Literature DB >> 6600929

Pharmacokinetic evaluation of ICI 35 868 in man. Single induction doses with different rates of injection.

H K Adam, L P Briggs, M Bahar, E J Douglas, J W Dundee.   

Abstract

Blood concentrations of ICI 35 868 have been measured in patients following a single bolus dose of 2 mg kg-1. Three different rates of injection of the anaesthetic agent (3-5s, 20s and 40 or 50s) were examined. Pharmacokinetic indices, derived from blood concentrations of ICI 35 868, were independent of the speed of injection. The blood profiles could be described by a two-compartment open model with a mean alpha-phase half-life of 2.5 min and a mean beta-phase half-life of 54.5 min. The mean total body clearance was 3454 ml min-1. Similar data were obtained from a 4-mg kg-1 dose. The mean recovery time (4.4 min) and concentration of ICI 35 868 at awakening (1.05 micrograms ml-1) were also independent of the rate of injection. Using the derived pharmacokinetic model, predictions of drug concentrations have been made for repeated bolus doses, or infusions, of ICI 35 868.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600929     DOI: 10.1093/bja/55.2.97

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

1.  A compartmental analysis of the pharmacokinetics of propofol in sheep.

Authors:  G L Ludbrook; R N Upton; C Grant; A Martinez
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

2.  Comparison of propofol infusion and isoflurane for maintenance of anesthesia for dentistry in mentally retarded patients.

Authors:  H Antila; J Valli; M Valtonen; J Kanto
Journal:  Anesth Prog       Date:  1992

3.  A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes.

Authors:  H K Jones; H C Kelly; M Hutchison; R A Yates; F Ross; C Lomax; S Freestone; D Webb
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.441

4.  Comparative evaluation of propofol and thiopentone for total intravenous anaesthesia.

Authors:  H Kashtan; G Edelist; J Mallon; D Kapala
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

5.  Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection.

Authors:  C A Knibbe; H J Voortman; L P Aarts; P F Kuks; R Lange; H J Langemeijer; M Danhof
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

6.  Anaesthesia for cardioversion: a comparison of propofol and thiopentone.

Authors:  M Valtonen; J Kanto; J Klossner
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

7.  Randomised Comparative Study on Propofol and Diazepam as a Sedating Agent in Day Care Surgery.

Authors:  Amit S Nirwan; Neha Jain; Micheal Pragasm; Deepashri Kamblimath; Anurag Bhargava; Saba Tiwari
Journal:  J Maxillofac Oral Surg       Date:  2013-06-15

Review 8.  Clinical pharmacokinetics of the newer intravenous anaesthetic agents.

Authors:  P J Davis; D R Cook
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

Review 9.  Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic.

Authors:  M S Langley; R C Heel
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

10.  A controlled investigation of propofol, thiopentone and methohexitone.

Authors:  M I Gold; E C Abraham; C Herrington
Journal:  Can J Anaesth       Date:  1987-09       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.